Gene
mark2a
- ID
- ZDB-GENE-030131-4145
- Name
- MAP/microtubule affinity-regulating kinase 2a
- Symbol
- mark2a Nomenclature History
- Previous Names
-
- fc75f05
- si:dkey-175m17.8
- wu:fc75f05 (1)
- Type
- protein_coding_gene
- Location
- Chr: 21 Mapping Details/Browsers
- Description
- Predicted to have protein serine/threonine kinase activity and tau-protein kinase activity. Predicted to be involved in intracellular signal transduction and microtubule cytoskeleton organization. Predicted to localize to cytoplasm. Orthologous to human MARK2 (microtubule affinity regulating kinase 2).
- Genome Resources
- Note
- None
- Comparative Information
- All Expression Data
- No data available
- Cross-Species Comparison
- High Throughput Data
- Thisse Expression Data
- No data available
Wild Type Expression Summary
- All Phenotype Data
- No data available
- Cross-Species Comparison
- Alliance
Phenotype Summary
Mutations
Human Disease
Domain, Family, and Site Summary
Type | InterPro ID | Name |
---|---|---|
Active_site | IPR008271 | Serine/threonine-protein kinase, active site |
Binding_site | IPR017441 | Protein kinase, ATP binding site |
Domain | IPR000719 | Protein kinase domain |
Domain | IPR001772 | Kinase associated domain 1 (KA1) |
Domain | IPR015940 | Ubiquitin-associated domain |
Domain | IPR049508 | Serine/threonine-protein kinase MARK 1-4, catalytic domain |
Homologous_superfamily | IPR011009 | Protein kinase-like domain superfamily |
Homologous_superfamily | IPR028375 | KA1 domain/Ssp2, C-terminal |
Domain Details Per Protein
Protein | Length | KA1 domain/Ssp2, C-terminal | Kinase associated domain 1 (KA1) | Protein kinase, ATP binding site | Protein kinase domain | Protein kinase-like domain superfamily | Serine/threonine-protein kinase, active site | Serine/threonine-protein kinase MARK 1-4, catalytic domain | Ubiquitin-associated domain |
---|---|---|---|---|---|---|---|---|---|
UniProtKB:A0A8M3AU19
|
772 | ||||||||
UniProtKB:A0A8M3ALM5
|
769 | ||||||||
UniProtKB:A0A8M3B4V1
|
782 | ||||||||
UniProtKB:A0A8M2B8C0
|
781 | ||||||||
UniProtKB:A0A8M2B8F7
|
770 | ||||||||
UniProtKB:A0A8M3B4V9
|
723 | ||||||||
UniProtKB:A0A8M2B8K8
|
769 | ||||||||
UniProtKB:E9QHU0
|
736 | ||||||||
UniProtKB:A0A8M3AU26
|
723 | ||||||||
UniProtKB:A0A8M3B4V5
|
760 | ||||||||
UniProtKB:A0A8M3AMC2
|
781 | ||||||||
UniProtKB:A0A8M3ALN0
|
760 | ||||||||
UniProtKB:A0A8M9PDA8
|
654 | ||||||||
UniProtKB:A0A8M3AX04
|
773 | ||||||||
UniProtKB:A0A8M3AMD0
|
753 |
Type | Name | Annotation Method | Has Havana Data | Length (nt) | Analysis |
---|---|---|---|---|---|
aberrant processed transcript |
mark2a-207
(1)
|
Ensembl | 854 nt | ||
mRNA |
mark2a-201
(1)
|
Ensembl | 2,280 nt | ||
mRNA |
mark2a-203
(1)
|
Ensembl | 455 nt | ||
mRNA |
mark2a-204
(1)
|
Ensembl | 726 nt | ||
mRNA |
mark2a-205
(1)
|
Ensembl | 3,084 nt | ||
mRNA |
mark2a-206
(1)
|
Ensembl | 419 nt | ||
mRNA |
mark2a-208
(1)
|
Ensembl | 2,271 nt | ||
ncRNA |
mark2a-006
(1)
|
Ensembl | 841 nt |
Interactions and Pathways
No data available
Plasmids
No data available